# Venture Capital Firms Type: group Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/venture-capital-firms-group Canonical HTML page: https://getstartupbrief.com/entity/venture-capital-firms-group ## Timeline - **2026-Q3 (projected)**: Congressional Hearings — House and Senate committees begin drafting specific AI regulatory bills based on the framework. - **2026-03-20**: White House Policy Framework — The administration releases the six-principle framework to Congress for legislative action. - **2024**: Voluntary Commitments — Major AI labs agree to voluntary safety testing and watermarking standards. - **2023-10-30**: Executive Order 14110 — President Biden issues the first major Executive Order on Safe, Secure, and Trustworthy AI. ## Recent coverage (9 stories) ### 20% Fewer Startups by 2035 if Digital Rules Stay Restrictive: Survey 2026-06-30 06:48:22 · Sentiment: Bearish · Impact: 7/10 · Sources: 2 A survey of 350 Indian startups reveals overwhelming operational strain from digital regulations, with 88% reporting constraints and 72% diverting R&D funds to compliance. The Oxford Economics report projects a 20% decline in startup formation over the next decade, costing 245,000 jobs by 2035. However, principles-based regulation could boost formation by 7% and add 80,000 jobs, offering a path forward. Full story: https://getstartupbrief.com/story/startup-formation-decline-20-percent-digital-rules ### White House Issues AI Policy Framework: Six Pillars to Reshape Tech Regulation 2026-03-20 14:19:42 · Sentiment: Neutral · Impact: 8/10 · Sources: 2 The White House has delivered a comprehensive AI policy framework to Congress, centered on six guiding principles designed to balance rapid innovation with national security and consumer safety. This move signals a transition from executive-led guidance to a formal legislative push that will fundamentally alter the compliance landscape for AI startups and venture capital due diligence. Full story: https://getstartupbrief.com/story/white-house-ai-policy-framework-congress-six-principles ### US Q4 GDP Growth Downgraded to 0.7%: Implications for Venture Capital 2026-03-13 23:30:46 · Sentiment: Bearish · Impact: 8/10 · Sources: 2 The US government has revised its fourth-quarter GDP growth estimate downward to a sluggish 0.7%, signaling a sharp cooling of the economy. This deceleration suggests a tightening of capital deployment and a continued shift toward capital efficiency among growth-stage startups. Full story: https://getstartupbrief.com/story/us-q4-gdp-downgrade-vc-impact ### Small Business Optimism Stalls as Profit Gains Clash with Sales Fears 2026-03-10 21:10:56 · Sentiment: Neutral · Impact: 5/10 · Sources: 3 The NFIB Small Business Optimism Index remained stagnant in early 2026, reflecting a tug-of-war between improved bottom-line profitability and deteriorating expectations for future sales. While internal efficiencies are driving margins, small business owners remain wary of macroeconomic headwinds including volatile energy costs and labor market pressures. Full story: https://getstartupbrief.com/story/small-business-optimism-nfib-march-2026 ### FDA to Incentivize Faster Drug Reviews with New Staff Bonus Program 2026-02-26 23:40:23 · Sentiment: Bullish · Impact: 7/10 · Sources: 5 The U.S. Food and Drug Administration is introducing a performance-based bonus system to reward staffers who complete drug reviews ahead of schedule. This regulatory shift aims to clear backlogs and could significantly shorten the path to market for biotech startups and their venture backers. Full story: https://getstartupbrief.com/story/fda-bonus-payments-speedy-drug-reviews ### FDA Unveils Regulatory Framework for Bespoke Rare Disease Therapies 2026-02-24 03:18:42 · Sentiment: Bullish · Impact: 8/10 · Sources: 2 The FDA has proposed a groundbreaking regulatory system designed to streamline the approval of customized, 'N-of-1' therapies for ultra-rare diseases. This shift marks a transition from traditional mass-market drug evaluation to a platform-based approach, potentially unlocking significant venture investment in precision medicine. Full story: https://getstartupbrief.com/story/fda-proposes-customized-drug-approval-system ### Trump Implements 15% Global Tariff: Implications for Tech and VC 2026-02-21 20:33:39 · Sentiment: Bearish · Impact: 8/10 · Sources: 2 President Donald Trump has officially raised the United States' global tariff rate to 15%, a sweeping protectionist move. This policy shift is expected to significantly disrupt global supply chains, increase costs for hardware startups, and reshape venture capital allocation toward domestic-first business models. Full story: https://getstartupbrief.com/story/trump-15-percent-global-tariff-impact ### Valuation Scrutiny and Volatility Stall 2026 IPO Pipeline 2026-02-21 01:04:43 · Sentiment: Bearish · Impact: 7/10 · Sources: 2 A wave of postponed and downsized initial public offerings is sweeping through the 2026 market as investors demand more realistic valuations. Heightened market volatility and the lackluster performance of recent market entrants have forced many late-stage startups to reconsider their exit timing. Full story: https://getstartupbrief.com/story/ipo-market-volatility-valuation-scrutiny-2026 ### Tariff Volatility: How Trump’s Trade Policy is Reshaping VC Strategy 2026-02-20 20:20:19 · Sentiment: Bearish · Impact: 8/10 · Sources: 2 President Trump’s aggressive use of tariffs as a primary economic lever is creating significant uncertainty for hardware and consumer startups. As the administration moves toward broader trade restrictions, venture capitalists are recalibrating risk models to account for supply chain disruptions and potential inflationary pressures. Full story: https://getstartupbrief.com/story/trump-tariffs-2026-vc-impact-analysis --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.